# Timing-dependent effects of melatonin supplementation on exercise performance and exercise-induced muscle damage: a systematic review and meta-analysis

**Authors:** Jintao Guo, Lin Zhou, Jinfa Gu, Jie Sun, Guangsong Liu, Chao Wei

PMC · DOI: 10.3389/fnut.2026.1742464 · Frontiers in Nutrition · 2026-02-13

## TL;DR

This study finds that taking melatonin in the evening improves athletic performance and reduces muscle damage, especially when taken before long exercise sessions.

## Contribution

The study reveals timing-dependent benefits of melatonin supplementation for athletic performance and muscle recovery.

## Key findings

- Evening melatonin with >6-h exercise intervals improves endurance and explosive power more than daytime use.
- Melatonin significantly reduces creatine kinase levels, indicating less muscle damage.
- Higher doses (6–10 mg) and evening timing provide greater benefits for athletes.

## Abstract

Melatonin, an endogenous neurohormone with both chronobiotic and antioxidant properties, has been proposed as a nutritional aid for recovery and performance optimization. However, its timing-dependent effects on athletic performance remain unclear. This systematic review and meta-analysis aimed to evaluate the timing-dependent effects of melatonin supplementation on exercise performance and exercise-induced muscle damage in athletes and physically active individuals.

A comprehensive search of PubMed, Web of Science, SPORTDiscus, and Cochrane Library was conducted from inception to September 2025. Only randomized controlled trials (RCTs) published in English examining melatonin versus placebo effects on athletic performance and muscle damage biomarkers were included.

In total, 19 RCTs involving 266 participants met the inclusion criteria. Meta-analysis revealed small effects on explosive power (SMD = 0.29, 95% CI: 0.05 to 0.53, p = 0.02, I2 = 0%) and moderate effects on endurance performance (SMD = 0.58, 95% CI: 0.29 to 0.87, p < 0.001, I2 = 46%). Melatonin significantly reduced creatine kinase levels (SMD = 0.59, 95% CI: 0.29 to 0.89, p < 0.0001, I2 = 0%), with non-significant effects on lactate dehydrogenase (SMD = 0.45, 95% CI: −0.03 to 0.94, p = 0.07, I2 = 56%). Subgroup analyses revealed timing-dependent effects: evening administration with >6-h exercise intervals produced superior benefits for both endurance performance and explosive power compared to daytime administration or shorter intervals. Higher doses (6–10 mg) and athlete populations demonstrated greater improvements, while adolescents (≤18 years) showed enhanced explosive power responses.

These findings suggest that melatonin supplementation, particularly when administered in the evening with adequate timing intervals, enhances endurance performance and reduces exercise-induced muscle damage in athletes during intensive training periods.

https://www.crd.york.ac.uk/PROSPERO/view/CRD420251178430, Identifier (CRD420251178430).

## Linked entities

- **Chemicals:** melatonin (PubChem CID 896)

## Full-text entities

- **Genes:** GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, THAS (thoracoabdominal syndrome) [NCBI Gene 7055] {aka TAS}, CAT (catalase) [NCBI Gene 847], ABCB7 (ATP binding cassette subfamily B member 7) [NCBI Gene 22] {aka ABC7, ASAT, Atm1p, EST140535}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** overweight (MESH:D050177), fatigue (MESH:D005221), obesity (MESH:D009765), inflammation (MESH:D007249), Muscle damage (MESH:D009133), EIMD (MESH:D000092202), muscle soreness (MESH:D063806), LDH (MESH:C538133)
- **Chemicals:** blood glucose (MESH:D001786), cholesterol (MESH:D002784), triglycerides (MESH:D014280), MDA (MESH:D015104), glucose (MESH:D005947), creatinine (MESH:D003404), lipid (MESH:D008055), malondialdehyde (MESH:D008315), Melatonin (MESH:D008550), indoleamine (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946080/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12946080/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946080/full.md

---
Source: https://tomesphere.com/paper/PMC12946080